查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
2026926

合成基因組學市場預測至2034年：按產品、應用、最終用戶和地區分類的全球分析

Synthetic Genomics Market Forecasts to 2034 - Global Analysis By Product (Adapters, DNA Template, Klenow Fragment, Modifying Enzymes, Primers and Other Products), Application, End User and By Geography
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 | 商品交期: 2-3個工作天內

價格

根據 Stratistics MRC 的數據，預計到 2026 年，全球合成基因組學市場規模將達到 456 億美元，並在預測期內以 14.6% 的複合年成長率成長，到 2034 年將達到 1357 億美元。

快速發展的合成生物學領域涵蓋遺傳物質的生成與操控，它也屬於合成基因體學市場。這包括合成DNA序列的創建、建構和改造，用於各種應用，例如建立基因改造生物、人工細胞和客製化基因迴路。合成基因組學在醫學領域至關重要，可用於藥物研發、基因治療和個人化醫療。此外，它還有助於在農業領域培育具有改良特性的基因改造作物。

根據世界經濟論壇 2021 年 9 月發布的數據，合成生物學的進步在開發針對病毒的 mRNA 疫苗方面具有應對流行病的巨大潛力。

增加對研發活動的投入

隨著合成基因組學的快速發展，需要更多資金投入研發，以促進創新和新技術的發展。這些投資正用於DNA合成、基因編輯和其他遺傳物質操作等尖端技術的研究。此外，研究舉措的資金支持不斷增加，也反映出公共和私營部門日益認知到合成基因組在醫療保健、農業和工業應用領域的巨大潛力。

研發成本高成本

基因工程的複雜性以及對最尖端科技的需求，使得中小企業和研究機構難以進入市場。開發先進的基因編輯工具、DNA合成技術和其他關鍵技術需要大量資金，這阻礙了許多人投入該領域。然而，高昂的初始投資和持續的研發成本也會限制企業在合成基因體學領域的探索和創新能力。

合成生物學解決方案的需求日益成長

合成基因組學是合成生物學的基礎，它正推動著各個領域對創新且適應性強的生物解決方案日益成長的需求。隨著企業和教育機構逐漸認知到合成基因組學在創建和改造遺傳物質方面的巨大潛力，對客製化生物系統的需求也隨之成長。這種需求的應用範圍十分廣泛，涵蓋工業生物技術、醫療保健和農業等領域。此外，合成基因組學還能夠設計出可執行特定功能的生物體，例如用於工業生產的生物基材料、具有增強性能的基因改造作物以及藥物製劑。

安全和生物安保問題

操縱遺傳物質和創造合成生物體的潛力引發了人們對合成基因組學可能被濫用於惡意目的的擔憂。為了緩解這些擔憂，各國政府和監管機構必須制定嚴格的法律，禁止非法取得基因技術。有效的安全措施至關重要，因為基因改造生物體可能被用於惡意用途，例如製造生物武器。然而，這些擔憂使得合成基因組市場的企業難以滿足合規要求，導致監管核准流程延誤和審查力道加大。

新冠疫情的感染疾病：

全球健康危機凸顯了尖端基因技術在疫苗研發、診斷和替代治療方法中的重要性。合成基因體學使得mRNA疫苗的快速研發成為可能，展現了此技術快速適應新型感染疾病的能力。疫情對市場成長軌跡產生了間接影響，原因包括研究舉措延誤、供應鏈中斷以及資源轉移到緊急醫療需求。資金籌措和經濟不確定性也對產業內的小規模參與企業造成了衝擊。

在預測期內，DNA模板部分預計將佔據最大佔有率。

由於DNA模板在遺傳物質的精確高效合成中發揮著至關重要的作用，因此它在合成基因組學市場中佔據了最大的佔有率。 DNA合成技術的進步，包括自動化DNA合成平台和創新方法，使得研究人員和生物技術專業人員能夠以前所未有的速度和精度設計和製造客製化的DNA序列。此外，基因治療、藥物研發和基因改造牲畜生產等各種應用領域對合成生物學解決方案的需求不斷成長，也推動了DNA模板領域的發展。

在預測期內，器官移植領域預計將呈現最高的複合年成長率。

器官移植為解決器官短缺問題提供了一種突破性方案，預計該領域在預測期內將實現盈利成長。為了解決器官排斥和器官短缺問題，合成基因組學正逐漸成為一種潛在的高效方法，用於生產具有更高相容性的器官和組織。此外，精準基因改造器官的能力使得移植器官能夠根據特定患者的需求進行客製化，從而降低免疫反應並提高移植成功率。

市佔率最大的地區：

在整個預測期內，亞太地區佔據最大的市場佔有率，這主要得益於該地區經濟的快速工業化和技術創新，以及合成基因組學在許多領域創新潛力的日益凸顯。中國、日本和印度等國家正大力投資研發，為合成基因體學的發展創造了理想的環境。學術機構、研究組織和生物技術公司積極推動前沿項目，促進創新並開拓新的應用領域。

複合年成長率最高的地區：

隨著精準醫療和個人化醫療的日益普及，亞太地區在醫療保健相關項目增加的推動下實現了盈利成長。合成基因體學是這些努力的關鍵技術，能夠實現基因介入、基因治療和診斷工具的個人化。合成基因組學技術的應用源自於其解決區域性健康挑戰和提供個人化醫療方案的潛力。此外，新加坡和中國等政府正積極支持合成生物學和生物技術領域的各項舉措，提供資源和基礎設施，以促進這些領域的研究和發展。

免費客製化服務：

所有購買此報告的客戶均可享受以下免費自訂選項之一：

  • 企業概況
    • 對其他市場參與者（最多 3 家公司）進行全面分析
    • 對主要公司進行SWOT分析（最多3家公司）
  • 區域細分
    • 應客戶要求，我們提供主要國家和地區的市場估算和預測，以及複合年成長率（註：需進行可行性檢查）。
  • 競爭性標竿分析
    • 根據產品系列、地理覆蓋範圍和策略聯盟對重點公司進行基準分析。

目錄

第1章執行摘要

第2章：引言

  • 概括
  • 相關利益者
  • 調查範圍
  • 調查方法
  • 研究材料

第3章 市場趨勢分析

  • 促進因素
  • 抑制因子
  • 機會
  • 威脅
  • 產品分析
  • 應用分析
  • 最終用戶分析
  • 新興市場
  • 新冠疫情的感染疾病

第4章：波特五力分析

  • 供應商的議價能力
  • 買方的議價能力
  • 替代品的威脅
  • 新進入者的威脅
  • 競爭公司之間的競爭

第5章 全球合成基因體學市場：依產品分類

  • 適配器
  • DNA模板
  • 克雷諾碎片
  • 修飾酵素
  • 底漆
  • 其他產品

第6章 全球合成基因體學市場：依應用分類

  • 細菌抗藥性
  • DNA列印
  • 創新疫苗和療法
  • 營養蛋白質和脂肪
  • 器官移植
  • 其他用途

第7章 全球合成基因體學市場：依最終用戶分類

  • 學術機構
  • 生技公司
  • 受託研究機構
  • 政府研究機構
  • 製藥公司
  • 其他最終用戶

第8章 全球合成基因體學市場：按地區分類

  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 英國
    • 義大利
    • 法國
    • 西班牙
    • 其他歐洲國家
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 紐西蘭
    • 韓國
    • 其他亞太國家
  • 南美洲
    • 阿根廷
    • 巴西
    • 智利
    • 其他南美國家
  • 中東和非洲
    • 沙烏地阿拉伯
    • UAE
    • 卡達
    • 南非
    • 其他中東和非洲國家

第9章 主要發展

  • 合約、夥伴關係、合作關係、合資企業
  • 收購與併購
  • 新產品發布
  • 業務拓展
  • 其他關鍵策略

第10章：公司簡介

  • Biocompare Inc
  • Boster Biological Technology
  • Eurofins Genomics
  • Genewiz
  • GenScript
  • Integrated DNA Technologies Inc
  • Synthetic Genomics Inc
  • Thermo Fisher Scientific Inc
  • Twist Bioscience
Product Code: SMRC24697

According to Stratistics MRC, the Global Synthetic Genomics Market is accounted for $45.6 billion in 2026 and is expected to reach $135.7billion by 2034 growing at a CAGR of 14.6% during the forecast period. The rapidly growing field of synthetic biology, which involves the production and manipulation of genetic material, is included in the Synthetic Genomics Market. It involves the creation, building, and refinement of synthetic DNA sequences for a variety of applications, including the creation of genetically modified creatures, artificial cells, and tailored genetic circuits. Synthetic genomics is essential to drug development, gene therapy, and customized medicine in the field of medicine. It aids in the creation of genetically engineered crops with enhanced attributes in agriculture.

According to a data published by the World Economic Forum in September 2021, the advancements in the synthetic biology have a vast potential to manage the pandemic for the development of mRNA vaccine against virus.

Market Dynamics:

Driver:

Growing investments in research and development activities

As synthetic genomics develops rapidly, additional funding for research and development is needed to promote innovation and new technologies. These investments fund the examination of cutting-edge methods for DNA synthesis, gene editing, and other genetic material manipulation. Additionally, growing financial support for research initiatives is a result of both the public and private sectors recognizing the enormous potential of synthetic genomes in healthcare, agriculture, and industrial applications.

Restraint:

High costs of research and development

Due to the complexity of genetic engineering and the requirement for cutting-edge technologies, smaller businesses and research institutions consider it difficult to enter the market. Significant money is needed to create advanced gene editing tools, DNA synthesis techniques, and other critical technologies, which prevents numerous individuals from working in this field. However, companies' capacity to explore and innovate in synthetic genomics may be constrained by the significant initial investment and ongoing research and development costs.

Opportunity:

Rising demand for synthetic biology solutions

Synthetic genomics, a fundamental aspect of synthetic biology, contributes to the growing demand for innovative and adaptable biological solutions in a range of sectors. Customized biological systems are becoming more and more in demand as companies and educational institutions realize the enormous promise synthetic genomics has for creating and modifying genetic material. Applications for this demand are wide-ranging and include industrial biotechnology, healthcare, and agriculture. Moreover, with the use of synthetic genomics, biological organisms can be designed to do specific duties, such as creating bio-based materials for industrial processes, genetically modified crops with improved features, and medicinal treatments.

Threat:

Security and biosecurity concerns

Fears regarding the exploitation of synthetic genomics for malevolent terminates are triggered by the manipulation of genetic material and the potential production of synthetic creatures. To mitigate these worries, governments and regulatory agencies must impose stringent laws that prohibit illegal access to genetic technologies. Effective safety precautions are necessary due to the possibility of creating genetically modified organisms with malicious intent, such as bioweapons. However, companies in the synthetic genome market find it difficult to manage compliance requirements as a result of these worries, which also slow down the regulatory approval process and raise scrutiny.

Covid-19 Impact:

The relevance of cutting-edge genetic technologies for vaccine development, diagnostics, and treatment alternatives has been demonstrated by the global health crisis. The rapid development of mRNA vaccinations was made possible by synthetic genomics, demonstrating the technology's capacity to adapt rapidly to new infections. The pandemic managed to indirectly affect the market's growth trajectory by delaying research initiatives, reversing supply chains, and directing resources to urgent healthcare requirements. Funding limitations and economic uncertainty had an impact on the industry's smaller participants.

The DNA template segment is expected to be the largest during the forecast period

Due to its crucial significance in the accurate and effective synthesis of genetic material, the DNA template segment held the largest share in the synthetic genomics market. Researchers and biotechnologists can design and manufacture customized DNA sequences with previously unattainable speed and accuracy because of advancements in DNA synthesis technology, including automated DNA synthesis platforms and innovative approaches. Furthermore, the growing need for synthetic biology solutions for a variety of applications, such as gene therapy, drug discovery, and the generation of genetically modified livestock, is the factor that is causing this rise in the DNA template sector.

The organ transplantation segment is expected to have the highest CAGR during the forecast period

Because organ transplantation has a transformative effect on addressing the challenges associated with organ shortages, the segment is expected to grow profitably during the projected period. To address the issues associated with organ rejection and scarcity, synthetic genomics has emerged as a potentially efficient way of producing organs and tissues with improved compatibility. Additionally, the capacity to precisely modify organs genetically offers the possibility of customizing grafts for particular patients, reducing immunological reactions, and raising transplant success rates.

Region with largest share:

Over the course of the projected period, the Asia Pacific region had the largest share of the market due to the region's economies experiencing rapid industrialization and technological improvement, as well as the increasing awareness of the revolutionary potential of synthetic genomics across numerous sectors. Significant R&D investments have been made by nations like China, Japan, and India, creating an optimal environment for the development of synthetic genomics. Cutting-edge initiatives are being actively promoted by academic institutions, research organizations, and biotech corporations, which promote innovation and the creation of new applications.

Region with highest CAGR:

With an increasing focus on precision medicine and tailored healthcare, the Asia-Pacific area is experiencing profitable growth as a result of an increase in healthcare-related projects. Because it renders it feasible to customize genetic interventions, gene therapies, and diagnostic tools, synthetic genomics is essential to these initiatives. The use of synthetic genomics technology is being propelled by its potential to address regional health concerns and offer customized medicinal therapies. Moreover, governments in nations like Singapore and China are actively supporting efforts in the domains of synthetic biology and biotechnology, offering resources and infrastructure to support the advancement of these fields' research and development.

Key players in the market

Some of the key players in Synthetic Genomics market include Biocompare Inc , Boster Biological Technology, Eurofins Genomics, Genewiz, GenScript, Integrated DNA Technologies Inc, Synthetic Genomics Inc, Thermo Fisher Scientific Inc and Twist Bioscience .

Key Developments:

In October 2023, Global genomics solutions provider Integrated DNA Technologies (IDT), an operating company in the Life Sciences segment of Danaher Corporation announced the completion of its new Therapeutic Oligonucleotide Manufacturing facility in Coralville, Iowa. The milestone marks a significant achievement in the company's 35-year-history-its entrance into the therapeutics space-and enables IDT to manufacture products for research use through to current good manufacturing practice (cGMP) grade cell and gene therapy reagents to provide researchers with a single partner that can help them rapidly transition from the lab to therapeutic development.

In February 2023, Ultima Genomics, Inc., a developer of a revolutionary new ultra-high throughput sequencing architecture, announced a strategic collaboration with global genomics solutions provider Integrated DNA Technologies (IDT) to enable key next generation sequencing (NGS) applications on Ultima platforms.

In February 2023, Twist Bioscience announces technology early access of enhanced whole genome sequencing solution at AGBT. eWGS is a novel solution that enables researchers to obtain simultaneous low-pass whole genome data together with deep coverage of selected regions, in a high-throughput and cost-effective workflow.

Products Covered:

  • Adapters
  • DNA Template
  • Klenow Fragment
  • Modifying Enzymes
  • Primers
  • Other Products

Applications Covered:

  • Bacterial Resistance
  • DNA Printing
  • Innovative Vaccines & Therapeutics
  • Nutritional Proteins & Oils
  • Organ Transplantation
  • Other Applications

End Users Covered:

  • Academic Institutions
  • Biotechnology Companies
  • Contract Research Organizations
  • Government Laboratories
  • Pharmaceutical companies
  • Other End Users

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2023, 2024, 2025, 2026, 2027, 2028, 2030, 2032 and 2034
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 Product Analysis
  • 3.7 Application Analysis
  • 3.8 End User Analysis
  • 3.9 Emerging Markets
  • 3.10 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global Synthetic Genomics Market, By Product

  • 5.1 Introduction
  • 5.2 Adapters
  • 5.3 DNA Template
  • 5.4 Klenow Fragment
  • 5.5 Modifying Enzymes
  • 5.6 Primers
  • 5.7 Other Products

6 Global Synthetic Genomics Market, By Application

  • 6.1 Introduction
  • 6.2 Bacterial Resistance
  • 6.3 DNA Printing
  • 6.4 Innovative Vaccines & Therapeutics
  • 6.5 Nutritional Proteins & Oils
  • 6.6 Organ Transplantation
  • 6.7 Other Applications

7 Global Synthetic Genomics Market, By End User

  • 7.1 Introduction
  • 7.2 Academic Institutions
  • 7.3 Biotechnology Companies
  • 7.4 Contract Research Organizations
  • 7.5 Government Laboratories
  • 7.6 Pharmaceutical companies
  • 7.7 Other End Users

8 Global Synthetic Genomics Market, By Geography

  • 8.1 Introduction
  • 8.2 North America
    • 8.2.1 US
    • 8.2.2 Canada
    • 8.2.3 Mexico
  • 8.3 Europe
    • 8.3.1 Germany
    • 8.3.2 UK
    • 8.3.3 Italy
    • 8.3.4 France
    • 8.3.5 Spain
    • 8.3.6 Rest of Europe
  • 8.4 Asia Pacific
    • 8.4.1 Japan
    • 8.4.2 China
    • 8.4.3 India
    • 8.4.4 Australia
    • 8.4.5 New Zealand
    • 8.4.6 South Korea
    • 8.4.7 Rest of Asia Pacific
  • 8.5 South America
    • 8.5.1 Argentina
    • 8.5.2 Brazil
    • 8.5.3 Chile
    • 8.5.4 Rest of South America
  • 8.6 Middle East & Africa
    • 8.6.1 Saudi Arabia
    • 8.6.2 UAE
    • 8.6.3 Qatar
    • 8.6.4 South Africa
    • 8.6.5 Rest of Middle East & Africa

9 Key Developments

  • 9.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 9.2 Acquisitions & Mergers
  • 9.3 New Product Launch
  • 9.4 Expansions
  • 9.5 Other Key Strategies

10 Company Profiling

  • 10.1 Biocompare Inc
  • 10.2 Boster Biological Technology
  • 10.3 Eurofins Genomics
  • 10.4 Genewiz
  • 10.5 GenScript
  • 10.6 Integrated DNA Technologies Inc
  • 10.7 Synthetic Genomics Inc
  • 10.8 Thermo Fisher Scientific Inc
  • 10.9 Twist Bioscience

List of Tables

  • Table 1 Global Synthetic Genomics Market Outlook, By Region (2023-2034) ($MN)
  • Table 2 Global Synthetic Genomics Market Outlook, By Product (2023-2034) ($MN)
  • Table 3 Global Synthetic Genomics Market Outlook, By Adapters (2023-2034) ($MN)
  • Table 4 Global Synthetic Genomics Market Outlook, By DNA Template (2023-2034) ($MN)
  • Table 5 Global Synthetic Genomics Market Outlook, By Klenow Fragment (2023-2034) ($MN)
  • Table 6 Global Synthetic Genomics Market Outlook, By Modifying Enzymes (2023-2034) ($MN)
  • Table 7 Global Synthetic Genomics Market Outlook, By Primers (2023-2034) ($MN)
  • Table 8 Global Synthetic Genomics Market Outlook, By Other Products (2023-2034) ($MN)
  • Table 9 Global Synthetic Genomics Market Outlook, By Application (2023-2034) ($MN)
  • Table 10 Global Synthetic Genomics Market Outlook, By Bacterial Resistance (2023-2034) ($MN)
  • Table 11 Global Synthetic Genomics Market Outlook, By DNA Printing (2023-2034) ($MN)
  • Table 12 Global Synthetic Genomics Market Outlook, By Innovative Vaccines & Therapeutics (2023-2034) ($MN)
  • Table 13 Global Synthetic Genomics Market Outlook, By Nutritional Proteins & Oils (2023-2034) ($MN)
  • Table 14 Global Synthetic Genomics Market Outlook, By Organ Transplantation (2023-2034) ($MN)
  • Table 15 Global Synthetic Genomics Market Outlook, By Other Applications (2023-2034) ($MN)
  • Table 16 Global Synthetic Genomics Market Outlook, By End User (2023-2034) ($MN)
  • Table 17 Global Synthetic Genomics Market Outlook, By Academic Institutions (2023-2034) ($MN)
  • Table 18 Global Synthetic Genomics Market Outlook, By Biotechnology Companies (2023-2034) ($MN)
  • Table 19 Global Synthetic Genomics Market Outlook, By Contract Research Organizations (2023-2034) ($MN)
  • Table 20 Global Synthetic Genomics Market Outlook, By Government Laboratories (2023-2034) ($MN)
  • Table 21 Global Synthetic Genomics Market Outlook, By Pharmaceutical companies (2023-2034) ($MN)
  • Table 22 Global Synthetic Genomics Market Outlook, By Other End Users (2023-2034) ($MN)
  • Table 23 North America Synthetic Genomics Market Outlook, By Country (2023-2034) ($MN)
  • Table 24 North America Synthetic Genomics Market Outlook, By Product (2023-2034) ($MN)
  • Table 25 North America Synthetic Genomics Market Outlook, By Adapters (2023-2034) ($MN)
  • Table 26 North America Synthetic Genomics Market Outlook, By DNA Template (2023-2034) ($MN)
  • Table 27 North America Synthetic Genomics Market Outlook, By Klenow Fragment (2023-2034) ($MN)
  • Table 28 North America Synthetic Genomics Market Outlook, By Modifying Enzymes (2023-2034) ($MN)
  • Table 29 North America Synthetic Genomics Market Outlook, By Primers (2023-2034) ($MN)
  • Table 30 North America Synthetic Genomics Market Outlook, By Other Products (2023-2034) ($MN)
  • Table 31 North America Synthetic Genomics Market Outlook, By Application (2023-2034) ($MN)
  • Table 32 North America Synthetic Genomics Market Outlook, By Bacterial Resistance (2023-2034) ($MN)
  • Table 33 North America Synthetic Genomics Market Outlook, By DNA Printing (2023-2034) ($MN)
  • Table 34 North America Synthetic Genomics Market Outlook, By Innovative Vaccines & Therapeutics (2023-2034) ($MN)
  • Table 35 North America Synthetic Genomics Market Outlook, By Nutritional Proteins & Oils (2023-2034) ($MN)
  • Table 36 North America Synthetic Genomics Market Outlook, By Organ Transplantation (2023-2034) ($MN)
  • Table 37 North America Synthetic Genomics Market Outlook, By Other Applications (2023-2034) ($MN)
  • Table 38 North America Synthetic Genomics Market Outlook, By End User (2023-2034) ($MN)
  • Table 39 North America Synthetic Genomics Market Outlook, By Academic Institutions (2023-2034) ($MN)
  • Table 40 North America Synthetic Genomics Market Outlook, By Biotechnology Companies (2023-2034) ($MN)
  • Table 41 North America Synthetic Genomics Market Outlook, By Contract Research Organizations (2023-2034) ($MN)
  • Table 42 North America Synthetic Genomics Market Outlook, By Government Laboratories (2023-2034) ($MN)
  • Table 43 North America Synthetic Genomics Market Outlook, By Pharmaceutical companies (2023-2034) ($MN)
  • Table 44 North America Synthetic Genomics Market Outlook, By Other End Users (2023-2034) ($MN)
  • Table 45 Europe Synthetic Genomics Market Outlook, By Country (2023-2034) ($MN)
  • Table 46 Europe Synthetic Genomics Market Outlook, By Product (2023-2034) ($MN)
  • Table 47 Europe Synthetic Genomics Market Outlook, By Adapters (2023-2034) ($MN)
  • Table 48 Europe Synthetic Genomics Market Outlook, By DNA Template (2023-2034) ($MN)
  • Table 49 Europe Synthetic Genomics Market Outlook, By Klenow Fragment (2023-2034) ($MN)
  • Table 50 Europe Synthetic Genomics Market Outlook, By Modifying Enzymes (2023-2034) ($MN)
  • Table 51 Europe Synthetic Genomics Market Outlook, By Primers (2023-2034) ($MN)
  • Table 52 Europe Synthetic Genomics Market Outlook, By Other Products (2023-2034) ($MN)
  • Table 53 Europe Synthetic Genomics Market Outlook, By Application (2023-2034) ($MN)
  • Table 54 Europe Synthetic Genomics Market Outlook, By Bacterial Resistance (2023-2034) ($MN)
  • Table 55 Europe Synthetic Genomics Market Outlook, By DNA Printing (2023-2034) ($MN)
  • Table 56 Europe Synthetic Genomics Market Outlook, By Innovative Vaccines & Therapeutics (2023-2034) ($MN)
  • Table 57 Europe Synthetic Genomics Market Outlook, By Nutritional Proteins & Oils (2023-2034) ($MN)
  • Table 58 Europe Synthetic Genomics Market Outlook, By Organ Transplantation (2023-2034) ($MN)
  • Table 59 Europe Synthetic Genomics Market Outlook, By Other Applications (2023-2034) ($MN)
  • Table 60 Europe Synthetic Genomics Market Outlook, By End User (2023-2034) ($MN)
  • Table 61 Europe Synthetic Genomics Market Outlook, By Academic Institutions (2023-2034) ($MN)
  • Table 62 Europe Synthetic Genomics Market Outlook, By Biotechnology Companies (2023-2034) ($MN)
  • Table 63 Europe Synthetic Genomics Market Outlook, By Contract Research Organizations (2023-2034) ($MN)
  • Table 64 Europe Synthetic Genomics Market Outlook, By Government Laboratories (2023-2034) ($MN)
  • Table 65 Europe Synthetic Genomics Market Outlook, By Pharmaceutical companies (2023-2034) ($MN)
  • Table 66 Europe Synthetic Genomics Market Outlook, By Other End Users (2023-2034) ($MN)
  • Table 67 Asia Pacific Synthetic Genomics Market Outlook, By Country (2023-2034) ($MN)
  • Table 68 Asia Pacific Synthetic Genomics Market Outlook, By Product (2023-2034) ($MN)
  • Table 69 Asia Pacific Synthetic Genomics Market Outlook, By Adapters (2023-2034) ($MN)
  • Table 70 Asia Pacific Synthetic Genomics Market Outlook, By DNA Template (2023-2034) ($MN)
  • Table 71 Asia Pacific Synthetic Genomics Market Outlook, By Klenow Fragment (2023-2034) ($MN)
  • Table 72 Asia Pacific Synthetic Genomics Market Outlook, By Modifying Enzymes (2023-2034) ($MN)
  • Table 73 Asia Pacific Synthetic Genomics Market Outlook, By Primers (2023-2034) ($MN)
  • Table 74 Asia Pacific Synthetic Genomics Market Outlook, By Other Products (2023-2034) ($MN)
  • Table 75 Asia Pacific Synthetic Genomics Market Outlook, By Application (2023-2034) ($MN)
  • Table 76 Asia Pacific Synthetic Genomics Market Outlook, By Bacterial Resistance (2023-2034) ($MN)
  • Table 77 Asia Pacific Synthetic Genomics Market Outlook, By DNA Printing (2023-2034) ($MN)
  • Table 78 Asia Pacific Synthetic Genomics Market Outlook, By Innovative Vaccines & Therapeutics (2023-2034) ($MN)
  • Table 79 Asia Pacific Synthetic Genomics Market Outlook, By Nutritional Proteins & Oils (2023-2034) ($MN)
  • Table 80 Asia Pacific Synthetic Genomics Market Outlook, By Organ Transplantation (2023-2034) ($MN)
  • Table 81 Asia Pacific Synthetic Genomics Market Outlook, By Other Applications (2023-2034) ($MN)
  • Table 82 Asia Pacific Synthetic Genomics Market Outlook, By End User (2023-2034) ($MN)
  • Table 83 Asia Pacific Synthetic Genomics Market Outlook, By Academic Institutions (2023-2034) ($MN)
  • Table 84 Asia Pacific Synthetic Genomics Market Outlook, By Biotechnology Companies (2023-2034) ($MN)
  • Table 85 Asia Pacific Synthetic Genomics Market Outlook, By Contract Research Organizations (2023-2034) ($MN)
  • Table 86 Asia Pacific Synthetic Genomics Market Outlook, By Government Laboratories (2023-2034) ($MN)
  • Table 87 Asia Pacific Synthetic Genomics Market Outlook, By Pharmaceutical companies (2023-2034) ($MN)
  • Table 88 Asia Pacific Synthetic Genomics Market Outlook, By Other End Users (2023-2034) ($MN)
  • Table 89 South America Synthetic Genomics Market Outlook, By Country (2023-2034) ($MN)
  • Table 90 South America Synthetic Genomics Market Outlook, By Product (2023-2034) ($MN)
  • Table 91 South America Synthetic Genomics Market Outlook, By Adapters (2023-2034) ($MN)
  • Table 92 South America Synthetic Genomics Market Outlook, By DNA Template (2023-2034) ($MN)
  • Table 93 South America Synthetic Genomics Market Outlook, By Klenow Fragment (2023-2034) ($MN)
  • Table 94 South America Synthetic Genomics Market Outlook, By Modifying Enzymes (2023-2034) ($MN)
  • Table 95 South America Synthetic Genomics Market Outlook, By Primers (2023-2034) ($MN)
  • Table 96 South America Synthetic Genomics Market Outlook, By Other Products (2023-2034) ($MN)
  • Table 97 South America Synthetic Genomics Market Outlook, By Application (2023-2034) ($MN)
  • Table 98 South America Synthetic Genomics Market Outlook, By Bacterial Resistance (2023-2034) ($MN)
  • Table 99 South America Synthetic Genomics Market Outlook, By DNA Printing (2023-2034) ($MN)
  • Table 100 South America Synthetic Genomics Market Outlook, By Innovative Vaccines & Therapeutics (2023-2034) ($MN)
  • Table 101 South America Synthetic Genomics Market Outlook, By Nutritional Proteins & Oils (2023-2034) ($MN)
  • Table 102 South America Synthetic Genomics Market Outlook, By Organ Transplantation (2023-2034) ($MN)
  • Table 103 South America Synthetic Genomics Market Outlook, By Other Applications (2023-2034) ($MN)
  • Table 104 South America Synthetic Genomics Market Outlook, By End User (2023-2034) ($MN)
  • Table 105 South America Synthetic Genomics Market Outlook, By Academic Institutions (2023-2034) ($MN)
  • Table 106 South America Synthetic Genomics Market Outlook, By Biotechnology Companies (2023-2034) ($MN)
  • Table 107 South America Synthetic Genomics Market Outlook, By Contract Research Organizations (2023-2034) ($MN)
  • Table 108 South America Synthetic Genomics Market Outlook, By Government Laboratories (2023-2034) ($MN)
  • Table 109 South America Synthetic Genomics Market Outlook, By Pharmaceutical companies (2023-2034) ($MN)
  • Table 110 South America Synthetic Genomics Market Outlook, By Other End Users (2023-2034) ($MN)
  • Table 111 Middle East & Africa Synthetic Genomics Market Outlook, By Country (2023-2034) ($MN)
  • Table 112 Middle East & Africa Synthetic Genomics Market Outlook, By Product (2023-2034) ($MN)
  • Table 113 Middle East & Africa Synthetic Genomics Market Outlook, By Adapters (2023-2034) ($MN)
  • Table 114 Middle East & Africa Synthetic Genomics Market Outlook, By DNA Template (2023-2034) ($MN)
  • Table 115 Middle East & Africa Synthetic Genomics Market Outlook, By Klenow Fragment (2023-2034) ($MN)
  • Table 116 Middle East & Africa Synthetic Genomics Market Outlook, By Modifying Enzymes (2023-2034) ($MN)
  • Table 117 Middle East & Africa Synthetic Genomics Market Outlook, By Primers (2023-2034) ($MN)
  • Table 118 Middle East & Africa Synthetic Genomics Market Outlook, By Other Products (2023-2034) ($MN)
  • Table 119 Middle East & Africa Synthetic Genomics Market Outlook, By Application (2023-2034) ($MN)
  • Table 120 Middle East & Africa Synthetic Genomics Market Outlook, By Bacterial Resistance (2023-2034) ($MN)
  • Table 121 Middle East & Africa Synthetic Genomics Market Outlook, By DNA Printing (2023-2034) ($MN)
  • Table 122 Middle East & Africa Synthetic Genomics Market Outlook, By Innovative Vaccines & Therapeutics (2023-2034) ($MN)
  • Table 123 Middle East & Africa Synthetic Genomics Market Outlook, By Nutritional Proteins & Oils (2023-2034) ($MN)
  • Table 124 Middle East & Africa Synthetic Genomics Market Outlook, By Organ Transplantation (2023-2034) ($MN)
  • Table 125 Middle East & Africa Synthetic Genomics Market Outlook, By Other Applications (2023-2034) ($MN)
  • Table 126 Middle East & Africa Synthetic Genomics Market Outlook, By End User (2023-2034) ($MN)
  • Table 127 Middle East & Africa Synthetic Genomics Market Outlook, By Academic Institutions (2023-2034) ($MN)
  • Table 128 Middle East & Africa Synthetic Genomics Market Outlook, By Biotechnology Companies (2023-2034) ($MN)
  • Table 129 Middle East & Africa Synthetic Genomics Market Outlook, By Contract Research Organizations (2023-2034) ($MN)
  • Table 130 Middle East & Africa Synthetic Genomics Market Outlook, By Government Laboratories (2023-2034) ($MN)
  • Table 131 Middle East & Africa Synthetic Genomics Market Outlook, By Pharmaceutical companies (2023-2034) ($MN)
  • Table 132 Middle East & Africa Synthetic Genomics Market Outlook, By Other End Users (2023-2034) ($MN)